Press releases
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Oct 22, 2019
Boston Scientific announced the commencement of a cash tender offer for up to $1.0 billion of outstanding senior notes.
-
Oct 1, 2019
Boston Scientific will webcast its conference call with financial results and business highlights for Q3 ended September 30, 2019.
-
Sep 26, 2019Study of abbreviated antiplatelet therapy for patients at high risk for bleeding after undergoing percutaneous coronary intervention
Study of abbreviated antiplatelet therapy for patients at high risk for bleeding after percutaneous coronary intervention.
-
Sep 18, 2019
Notably, key data from the EVOLVE Short DAPT study of the SYNERGY stent will be featured during a late-breaking science session.
-
Aug 20, 2019
Boston Scientific CEO Mike Mahoney will participate in a conference in September 2019. Learn how to join the webcast or watch the replay.